Loading...
Header Logo
Keywords
Last Name
Institution

JEFFREY SCOTT WEFEL

TitleAssociate Professor
InstitutionMD Anderson
DepartmentNeuro-Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Noll KR, Sullaway CM, Wefel JS. Depressive symptoms and executive function in relation to survival in patients with glioblastoma. J Neurooncol. 2019 Mar; 142(1):183-191. PMID: 30680509.
      View in: PubMed
    2. Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ, Movsas B. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. 2019 Jan 01; 84(1):66-76. PMID: 29618054.
      View in: PubMed
    3. Harrison RA, Kesler SR, Johnson JM, Penas-Prado M, Sullaway CM, Wefel JS. Neurocognitive dysfunction in adult cerebellar medulloblastoma. Psychooncology. 2019 Jan; 28(1):131-138. PMID: 30315720.
      View in: PubMed
    4. Harrison RA, Wefel JS. Neurocognitive Function in Adult Cancer Patients. Neurol Clin. 2018 Aug; 36(3):653-674. PMID: 30072075.
      View in: PubMed
    5. Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive Changes in Cancer Survivors. Am Soc Clin Oncol Educ Book. 2018 May 23; (38):795-806. PMID: 30231372.
      View in: PubMed
    6. Noll KR, Bradshaw ME, Rexer J, Wefel JS. Neuropsychological Practice in the Oncology Setting. Arch Clin Neuropsychol. 2018 May 01; 33(3):344-353. PMID: 29718081.
      View in: PubMed
    7. Camidge DR, Lee EQ, Lin NU, Margolin K, Ahluwalia MS, Bendszus M, Chang SM, Dancey J, de Vries EGE, Harris GJ, Hodi FS, Lassman AB, Macdonald DR, Peereboom DM, Schiff D, Soffietti R, van den Bent MJ, Wefel JS, Wen PY. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 2018 01; 19(1):e20-e32. PMID: 29304358.
      View in: PubMed
    8. Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 2018 01; 19(1):e33-e42. PMID: 29304360.
      View in: PubMed
    9. Wefel JS, Parsons MW, Gondi V, Brown PD. Neurocognitive aspects of brain metastasis. Handb Clin Neurol. 2018; 149:155-165. PMID: 29307352.
      View in: PubMed
    10. Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V. Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? J Clin Oncol. 2018 Feb 10; 36(5):483-491. PMID: 29272161.
      View in: PubMed
    11. Moruno-Manchon JF, Uzor NE, Kesler SR, Wefel JS, Townley DM, Nagaraja AS, Pradeep S, Mangala LS, Sood AK, Tsvetkov AS. Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy. Mol Cell Neurosci. 2018 01; 86:65-71. PMID: 29180229.
      View in: PubMed
    12. Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma. Neurooncol Pract. 2018 Aug; 5(3):184-193. PMID: 30094046.
      View in: PubMed
    13. Schagen SB, Wefel JS. Post-traumatic Stress as the Primary Cause for Cognitive Decline-Not the Whole Story, and Perhaps No Story at All. J Natl Cancer Inst. 2017 10 01; 109(10). PMID: 28521366.
      View in: PubMed
    14. Salek KE, Hassan IS, Kotrotsou A, Abrol S, Faro SH, Mohamed FB, Zinn PO, Wei W, Li N, Kumar AJ, Weinberg JS, Wefel JS, Kesler SR, Liu HA, Hou P, Stafford RJ, Prabhu S, Sawaya R, Colen RR. Silent Sentence Completion Shows Superiority Localizing Wernicke's Area and Activation Patterns of Distinct Language Paradigms Correlate with Genomics: Prospective Study. Sci Rep. 2017 Sep 21; 7(1):12054. PMID: 28935966.
      View in: PubMed
    15. Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck. 2017 10; 39(10):2048-2056. PMID: 28763137.
      View in: PubMed
    16. Wefel JS, Noll KR, Rao G, Cahill DP. Reply to Freyschlag et al. Neuro Oncol. 2017 04 01; 19(4):598-599. PMID: 28339696.
      View in: PubMed
    17. Nayak L, de Groot J, Wefel JS, Cloughesy TF, Lieberman F, Chang SM, Omuro A, Drappatz J, Batchelor TT, DeAngelis LM, Gilbert MR, Aldape KD, Yung AW, Fisher J, Ye X, Chen A, Grossman S, Prados M, Wen PY. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas. J Neurooncol. 2017 03; 132(1):181-188. PMID: 28116649.
      View in: PubMed
    18. Moruno-Manchon JF, Uzor NE, Kesler SR, Wefel JS, Townley DM, Nagaraja AS, Pradeep S, Mangala LS, Sood AK, Tsvetkov AS. TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging (Albany NY). 2016 12 16; 8(12):3507-3519. PMID: 27992857.
      View in: PubMed
    19. Kesler SR, Noll K, Cahill DP, Rao G, Wefel JS. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma. J Neurooncol. 2017 02; 131(3):565-574. PMID: 27848136.
      View in: PubMed
    20. Wefel JS, Noll KR, Rao G, Cahill DP. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Neuro Oncol. 2016 12; 18(12):1656-1663. PMID: 27576872.
      View in: PubMed
    21. Manchon JF, Dabaghian Y, Uzor NE, Kesler SR, Wefel JS, Tsvetkov AS. Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Sci Rep. 2016 05 11; 6:25705. PMID: 27168474.
      View in: PubMed
    22. Day J, Yust-Katz S, Cachia D, Wefel J, Katz LH, Tremont I, Bulbeck H, Armstrong T, Rooney AG. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2016 Apr 13; 4:CD011376. PMID: 27074263.
      View in: PubMed
    23. Noll KR, Ziu M, Weinberg JS, Wefel JS. Neurocognitive functioning in patients with glioma of the left and right temporal lobes. J Neurooncol. 2016 06; 128(2):323-31. PMID: 27022915; PMCID: PMC4884162 [Available on 06/01/17].
    24. Wefel JS, Noll KR, Scheurer ME. Neurocognitive functioning and genetic variation in patients with primary brain tumours. Lancet Oncol. 2016 Mar; 17(3):e97-e108. PMID: 26972863.
      View in: PubMed
    25. Blakeley JO, Coons SJ, Corboy JR, Kline Leidy N, Mendoza TR, Wefel JS. Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations. Neuro Oncol. 2016 Mar; 18 Suppl 2:ii13-ii20. PMID: 26989128; PMCID: PMC4795998 [Available on 03/01/17].
    26. Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, Agar NY, Ryabin N, Farooq S, Lawler E, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU. Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. J Clin Oncol. 2016 Mar 20; 34(9):945-52. PMID: 26834058.
      View in: PubMed
    27. Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psychooncology. 2017 05; 26(5):617-624. PMID: 26677053.
      View in: PubMed
    28. Noll KR, Weinberg JS, Ziu M, Wefel JS. Verbal Learning Processes in Patients with Glioma of the Left and Right Temporal Lobes. Arch Clin Neuropsychol. 2016 Feb; 31(1):37-46. PMID: 26537777; PMCID: PMC4718189 [Available on 02/01/17].
    29. Noll KR, Weinberg JS, Ziu M, Benveniste RJ, Suki D, Wefel JS. Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma. Neurosurgery. 2015 Nov; 77(5):777-85. PMID: 26317672; PMCID: PMC4831270 [Available on 11/01/16].
    30. Noll KR, Wefel JS. Response to "From histology to neurocognition: the influence of tumor grade in glioma of the left temporal lobe on neurocognitive function". Neuro Oncol. 2015 Oct; 17(10):1421-2. PMID: 26395063; PMCID: PMC4578593 [Available on 10/01/16].
    31. Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancré V, Lange M, Castel H. Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. J Pain Symptom Manage. 2015 Dec; 50(6):830-41. PMID: 26344551.
      View in: PubMed
    32. Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS. Genetic Modulation of Neurocognitive Function in Glioma Patients. Clin Cancer Res. 2015 Jul 15; 21(14):3340-6. PMID: 25904748.
      View in: PubMed
    33. Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015 Mar; 65(2):123-38. PMID: 25483452; PMCID: PMC4355212.
    34. Wefel JS. Neuro-Oncology Practice: Time Flies When You Are Having Fun! Neurooncol Pract. 2014 Dec; 1(4):143-144. PMID: 26034625.
      View in: PubMed
    35. Noll KR, Sullaway C, Ziu M, Weinberg JS, Wefel JS. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection. Neuro Oncol. 2015 Apr; 17(4):580-7. PMID: 25227126; PMCID: PMC4483071.
    36. Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, Scherwath A, Schrauwen W, Wefel JS. Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions. EJC Suppl. 2014 Jun; 12(1):29-40. PMID: 26217164; PMCID: PMC4250534.
    37. Gilbert MR, Dignam J, Pugh S, Armstrong TS, Wefel JS, Aldape K, Stupp R, Hegi M, Won M, Curran WJ, Mehta MP. Reply to M.C. Chamberlain. J Clin Oncol. 2014 May 20; 32(15):1634-5. PMID: 24752060; PMCID: PMC4026583.
    38. Wefel JS, Kornet RL, Schagen SB. Systemically treated breast cancer patients and controls: an evaluation of the presence of noncredible performance. J Int Neuropsychol Soc. 2014 Apr; 20(4):357-69. PMID: 24607070.
      View in: PubMed
    39. Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJ, Mehta MP. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20; 370(8):699-708. PMID: 24552317; PMCID: PMC4201043.
    40. Wefel JS, Vidrine DJ, Marani SK, Swartz RJ, Veramonti TL, Meyers CA, Hoekstra HJ, Hoekstra-Weebers JE, Gritz ER. A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psychooncology. 2014 Jun; 23(6):626-33. PMID: 24339329; PMCID: PMC4066616.
    41. Kesler SR, Watson C, Koovakkattu D, Lee C, O'Hara R, Mahaffey ML, Wefel JS. Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav. 2013 Dec; 7(4):501-10. PMID: 23536015; PMCID: PMC3731420.
    42. Armstrong TS, Wefel JS, Wang M, Gilbert MR, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman DG, Choucair AK, Mehta M. Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol. 2013 Nov 10; 31(32):4076-84. PMID: 24101048; PMCID: PMC3816957.
    43. Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ, Mehta MP. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol. 2013 Nov 10; 31(32):4085-91. PMID: 24101040; PMCID: PMC3816958.
    44. Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013 Dec 01; 119(23):4188-95. PMID: 24105672; PMCID: PMC3834212.
    45. Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e396-406. PMID: 23993384.
      View in: PubMed
    46. Schagen SB, Wefel JS. Chemotherapy-related changes in cognitive functioning. EJC Suppl. 2013 Sep; 11(2):225-32. PMID: 26217131; PMCID: PMC4041313.
    47. Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e407-16. PMID: 23993385.
      View in: PubMed
    48. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013 Oct; 15(10):1429-37. PMID: 23956241; PMCID: PMC3779047.
    49. Welsh JW, McGovern SL, Wefel JS, Komaki R, Brown PD, Soh HE. Reply to v.R. Bhatt et Al and m.C. Chamberlain. J Clin Oncol. 2013 Sep 01; 31(25):3165-6. PMID: 23943829.
      View in: PubMed
    50. Kesler SR, Wefel JS, Hosseini SM, Cheung M, Watson CL, Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci U S A. 2013 Jul 09; 110(28):11600-5. PMID: 23798392; PMCID: PMC3710809.
    51. Johnson DR, Wefel JS. Relationship between cognitive function and prognosis in glioblastoma. CNS Oncol. 2013 Mar; 2(2):195-201. PMID: 25057978.
      View in: PubMed
    52. Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol. 2013 Mar 01; 31(7):895-902. PMID: 23341526; PMCID: PMC3577951.
    53. Meharry MR, Dawson D, Wefel JS, Harless JD, Kummet CM, Xiao X. The effect of surface defects in early caries assessment using quantitative light-induced fluorescence (QLF) and micro-digital-photography (MDP). J Dent. 2012 Nov; 40(11):955-61. PMID: 22892465.
      View in: PubMed
    54. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012 Jun; 12(3):267-75. PMID: 22453825.
      View in: PubMed
    55. Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol. 2012 Jun; 14(6):808-16. PMID: 22508762; PMCID: PMC3367851.
    56. Armstrong TS, Wefel JS, Gning I, Acquaye A, Vera-Bolanos E, Gilbert MR, Cleeland CS, Mendoza T. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 2012 Oct 15; 118(20):5026-37. PMID: 22415423.
      View in: PubMed
    57. Schapiro R, Ferson D, Prabhu SS, Tummula S, Wefel J, Rao G. A technique for mapping cortical areas associated with speech arrest. Stereotact Funct Neurosurg. 2012; 90(2):118-23. PMID: 22398728.
      View in: PubMed
    58. Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012 Mar; 107(1):165-74. PMID: 21964738.
      View in: PubMed
    59. Wu AS, Witgert ME, Lang FF, Xiao L, Bekele BN, Meyers CA, Ferson D, Wefel JS. Neurocognitive function before and after surgery for insular gliomas. J Neurosurg. 2011 Dec; 115(6):1115-25. PMID: 21905800.
      View in: PubMed
    60. Itthagarun A, Verma S, Lalloo R, King NM, Wefel JS, Nair RG. Effects of fluoridated milk on artificial enamel carious lesions: a pH cycling study. J Dent. 2011 Dec; 39(12):817-24. PMID: 21907756.
      View in: PubMed
    61. Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jun; 13(6):660-8. PMID: 21558074; PMCID: PMC3107095.
    62. van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011 Jun; 12(6):583-93. PMID: 21474379.
      View in: PubMed
    63. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1487-95. PMID: 20399573; PMCID: PMC2908725.
    64. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011 Jul; 12(7):703-8. PMID: 21354373.
      View in: PubMed
    65. Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol. 2011 Mar; 13(3):353-61. PMID: 21310734; PMCID: PMC3064608.
    66. Martínez-Mier EA, Cury JA, Heilman JR, Katz BP, Levy SM, Li Y, Maguire A, Margineda J, O'Mullane D, Phantumvanit P, Soto-Rojas AE, Stookey GK, Villa A, Wefel JS, Whelton H, Whitford GM, Zero DT, Zhang W, Zohouri V. Development of gold standard ion-selective electrode-based methods for fluoride analysis. Caries Res. 2011; 45(1):3-12. PMID: 21160184; PMCID: PMC3696354.
    67. Wefel JS, Vidrine DJ, Veramonti TL, Meyers CA, Marani SK, Hoekstra HJ, Hoekstra-Weebers JE, Shahani L, Gritz ER. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer. 2011 Jan 01; 117(1):190-6. PMID: 20737560.
      View in: PubMed
    68. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010 Jul 15; 116(14):3348-56. PMID: 20564075.
      View in: PubMed
    69. Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery. 2009 Dec; 146(6):1116-22. PMID: 19879613.
      View in: PubMed
    70. Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc. 2009 Nov; 15(6):1002-11. PMID: 19807940.
      View in: PubMed
    71. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009 Nov; 10(11):1037-44. PMID: 19801201.
      View in: PubMed
    72. Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA. Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Arch Clin Neuropsychol. 2009 Nov; 24(7):689-98. PMID: 19767298.
      View in: PubMed
    73. Wefel JS. NovaMin: likely clinical success. Adv Dent Res. 2009; 21(1):40-3. PMID: 19717409.
      View in: PubMed
    74. Pitts NB, Wefel JS. Remineralization/desensitization: what is known? What is the future? Adv Dent Res. 2009; 21(1):83-6. PMID: 19717415.
      View in: PubMed
    75. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008 Dec; 13(12):1285-95. PMID: 19019972.
      View in: PubMed
    76. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008 Jun; 18(2):121-31. PMID: 18415683.
      View in: PubMed
    77. Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, Puduvalli VK, Colman H, Hess KR, Yung WK. A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro Oncol. 2008 Apr; 10(2):208-15. PMID: 18316473; PMCID: PMC2613823.
    78. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008 Apr; 19(4):623-9. PMID: 17974553.
      View in: PubMed
    79. Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, Evans DB, Perrier ND. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug; 13(4):338-44. PMID: 17669708.
      View in: PubMed
    80. Itthagarun A, Thaveesangpanich P, King NM, Tay FR, Wefel JS. Effects of different amounts of a low fluoride toothpaste on primary enamel lesion progression: a preliminary study using in vitro pH-cycling system. Eur Arch Paediatr Dent. 2007 Mar; 8(1):69-73. PMID: 17394894.
      View in: PubMed
    81. Chang EL, Wefel JS, Maor MH, Hassenbusch SJ, Mahajan A, Lang FF, Woo SY, Mathews LA, Allen PK, Shiu AS, Meyers CA. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007 Feb; 60(2):277-83; discussion 283-4. PMID: 17290178.
      View in: PubMed
    82. Timmons SR, Harless JD, Hogan MM, Eckert GJ, Marek CL, Drake DR, Wefel JS. Effect of an alcohol-free, 1% chlorhexidine gel as an adjunct to a fluoridated dentifrice using an intraoral crown model. Caries Res. 2007; 41(3):190-7. PMID: 17426398.
      View in: PubMed
    83. Kayl AE, Wefel JS, Meyers CA. Chemotherapy and cognition: effects, potential mechanisms, and management. Am J Ther. 2006 Jul-Aug; 13(4):362-9. PMID: 16858172.
      View in: PubMed
    84. Heflin LH, Meyerowitz BE, Hall P, Lichtenstein P, Johansson B, Pedersen NL, Gatz M. Re: Cancer as a risk factor for dementia: a house built on shifting sand. J Natl Cancer Inst. 2005 Oct 19; 97(20):1550-1; author reply 1551-2. PMID: 16234571.
      View in: PubMed
    85. Thaveesangpanich P, Itthagarun A, King NM, Wefel JS. The effects of child formula toothpastes on enamel caries using two in vitro pH-cycling models. Int Dent J. 2005 Aug; 55(4):217-23. PMID: 16167610.
      View in: PubMed
    86. Wefel JS, Meyers CA. Cancer as a risk factor for dementia: a house built on shifting sand. J Natl Cancer Inst. 2005 Jun 01; 97(11):788-9. PMID: 15928294.
      View in: PubMed
    87. Maruff P, Falleti MG, Collie A. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial. Cancer. 2004 Nov 01; 101(9):2143-4; author reply 2144-5. PMID: 15382092.
      View in: PubMed
    88. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma?: a prologue. Cancer. 2004 Aug 01; 101(3):466-75. PMID: 15274059.
      View in: PubMed
    89. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004 Jun 01; 100(11):2292-9. PMID: 15160331.
      View in: PubMed
    90. Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer. 2004 May 04; 90(9):1691-6. PMID: 15150608; PMCID: PMC2410277.
    91. Atchison TB, Sander AM, Struchen MA, High WM, Roebuck TM, Contant CF, Wefel JS, Novack TA, Sherer M. Relationship between neuropsychological test performance and productivity at 1-year following traumatic brain injury. Clin Neuropsychol. 2004 May; 18(2):249-65. PMID: 15587672.
      View in: PubMed
    92. Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003 Oct 01; 21(19):3557-8. PMID: 12913103.
      View in: PubMed
    93. Ivancakova R, Hogan MM, Harless JD, Wefel JS. Effect of fluoridated milk on progression of root surface lesions in vitro under pH cycling conditions. Caries Res. 2003 May-Jun; 37(3):166-71. PMID: 12740538.
      View in: PubMed
    94. AL-Helal AS, Armstrong SR, Xie XJ, Wefel JS. Effect of smear layer on root demineralization adjacent to resin-modified glass ionomer. J Dent Res. 2003 Feb; 82(2):146-50. PMID: 12562890.
      View in: PubMed
    95. Wefel JS, Stanford CM, Ament DK, Hogan MM, Harless JD, Pfarrer AM, Ramsey LL, Leusch MS, Biesbrock AR. In situ evaluation of sodium hexametaphosphate-containing dentifrices. Caries Res. 2002 Mar-Apr; 36(2):122-8. PMID: 12037369.
      View in: PubMed
    96. Ikebe K, Ettinger RL, Wefel JS. In vitro evaluation of fluoride-releasing restorative materials for sealing the root canals of overdenture abutments. Int J Prosthodont. 2001 Nov-Dec; 14(6):556-62. PMID: 12066703.
      View in: PubMed
    97. Hsu CY, Jordan TH, Dederich DN, Wefel JS. Laser-matrix-fluoride effects on enamel demineralization. J Dent Res. 2001 Sep; 80(9):1797-801. PMID: 11926236.
      View in: PubMed
    98. Itthagarun A, King NM, Wefel JS, Tay FR, Pashley DH. The effect of fluoridated and non-fluoridated rewetting agents on in vitro recurrent caries. J Dent. 2001 May; 29(4):255-73. PMID: 11525227.
      View in: PubMed
    99. Levy SM, Warren JJ, Davis CS, Kirchner HL, Kanellis MJ, Wefel JS. Patterns of fluoride intake from birth to 36 months. J Public Health Dent. 2001; 61(2):70-7. PMID: 11474917.
      View in: PubMed
    100. Levy SM, McGrady JA, Bhuridej P, Warren JJ, Heilman JR, Wefel JS. Factors affecting dentifrice use and ingestion among a sample of U.S. preschoolers. Pediatr Dent. 2000 Sep-Oct; 22(5):389-94. PMID: 11048307.
      View in: PubMed
    101. Hsu CY, Jordan TH, Dederich DN, Wefel JS. Effects of low-energy CO2 laser irradiation and the organic matrix on inhibition of enamel demineralization. J Dent Res. 2000 Sep; 79(9):1725-30. PMID: 11023270.
      View in: PubMed
    102. Jensen ME, Donly K, Wefel JS. Assessment of the effect of selected snack foods on the remineralization/demineralization of enamel and dentin. J Contemp Dent Pract. 2000 Aug 15; 1(3):1-17. PMID: 12167879.
      View in: PubMed
    103. Itthagarun A, Wei SH, Wefel JS. The effect of different commercial dentifrices on enamel lesion progression: an in vitro pH-cycling study. Int Dent J. 2000 Feb; 50(1):21-8. PMID: 10945176.
      View in: PubMed
    104. Itthagarun A, Wei SH, Wefel JS. Morphology of initial lesions of enamel treated with different commercial dentifrices using a pH cycling model: scanning electron microscopy observations. Int Dent J. 1999 Dec; 49(6):352-60. PMID: 10907434.
      View in: PubMed
    105. Heilman JR, Kiritsy MC, Levy SM, Wefel JS. Assessing fluoride levels of carbonated soft drinks. J Am Dent Assoc. 1999 Nov; 130(11):1593-9. PMID: 10573939.
      View in: PubMed
    106. Wefel JS, Hoyt BD, Massma PJ. Neuropsychological functioning in depressed versus nondepressed participants with Alzheimer's disease. Clin Neuropsychol. 1999 Aug; 13(3):249-57. PMID: 10726596.
      View in: PubMed
    107. Todd MA, Staley RN, Kanellis MJ, Donly KJ, Wefel JS. Effect of a fluoride varnish on demineralization adjacent to orthodontic brackets. Am J Orthod Dentofacial Orthop. 1999 Aug; 116(2):159-67. PMID: 10434089.
      View in: PubMed
    108. Donly KJ, Segura A, Wefel JS, Hogan MM. Evaluating the effects of fluoride-releasing dental materials on adjacent interproximal caries. J Am Dent Assoc. 1999 Jun; 130(6):817-25. PMID: 10377639.
      View in: PubMed
    109. Chang YL, Stanford CM, Wefel JS, Keller JC. Osteoblastic cell attachment to hydroxyapatite-coated implant surfaces in vitro. Int J Oral Maxillofac Implants. 1999 Mar-Apr; 14(2):239-47. PMID: 10212541.
      View in: PubMed
    110. Vorhies AB, Donly KJ, Staley RN, Wefel JS. Enamel demineralization adjacent to orthodontic brackets bonded with hybrid glass ionomer cements: an in vitro study. Am J Orthod Dentofacial Orthop. 1998 Dec; 114(6):668-74. PMID: 9844206.
      View in: PubMed
    111. Hsu CY, Donly KJ, Drake DR, Wefel JS. Effects of aged fluoride-containing restorative materials on recurrent root caries. J Dent Res. 1998 Feb; 77(2):418-25. PMID: 9465175.
      View in: PubMed
    112. Segura A, Donly KJ, Wefel JS, Drake D. Effect of enamel microabrasion on bacterial colonization. Am J Dent. 1997 Dec; 10(6):272-4. PMID: 9590914.
      View in: PubMed
    113. Närhi TO, Ettinger RL, Heilman JR, Wefel JS. Salivary fluoride levels in overdenture wearers after topical fluoride gel application. Int J Prosthodont. 1997 Nov-Dec; 10(6):553-61. PMID: 9495177.
      View in: PubMed
    114. Ettinger RL, Olson RJ, Wefel JS, Asmussen C. In vitro evaluation of topical fluorides for overdenture abutments. J Prosthet Dent. 1997 Sep; 78(3):309-14. PMID: 9297649.
      View in: PubMed
    115. Suhr J, Tranel D, Wefel J, Barrash J. Memory performance after head injury: contributions of malingering, litigation status, psychological factors, and medication use. J Clin Exp Neuropsychol. 1997 Aug; 19(4):500-14. PMID: 9342686.
      View in: PubMed
    116. Heilman JR, Kiritsy MC, Levy SM, Wefel JS. Fluoride concentrations of infant foods. J Am Dent Assoc. 1997 Jul; 128(7):857-63. PMID: 9231600.
      View in: PubMed
    117. Segura A, Donly KJ, Wefel JS. The effects of microabrasion on demineralization inhibition of enamel surfaces. Quintessence Int. 1997 Jul; 28(7):463-6. PMID: 9477896.
      View in: PubMed
    118. Marinelli CB, Donly KJ, Wefel JS, Jakobsen JR, Denehy GE. An in vitro comparison of three fluoride regimens on enamel remineralization. Caries Res. 1997; 31(6):418-22. PMID: 9353580.
      View in: PubMed
    119. Heilman JR, Jordan TH, Warwick R, Wefel JS. Remineralization of root surfaces demineralized in solutions of differing fluoride levels. Caries Res. 1997; 31(6):423-8. PMID: 9353581.
      View in: PubMed
    120. ten Cate JM, Dundon KA, Vernon PG, Damato FA, Huntington E, Exterkate RA, Wefel JS, Jordan T, Stephen KW, Roberts AJ. Preparation and measurement of artificial enamel lesions, a four-laboratory ring test. Caries Res. 1996; 30(6):400-7. PMID: 8946105.
      View in: PubMed
    121. Levy SM, Kohout FJ, Kiritsy MC, Heilman JR, Wefel JS. Infants' fluoride ingestion from water, supplements and dentifrice. J Am Dent Assoc. 1995 Dec; 126(12):1625-32. PMID: 7499663.
      View in: PubMed
    122. Wefel JS. Working Group Report 2: In situ caries models, saliva, microbiology, and statistical considerations. Adv Dent Res. 1995 Nov; 9(3):335-7. PMID: 8615953.
      View in: PubMed
    123. Wefel JS, Jensen ME, Triolo PT, Faller RV, Hogan MM, Bowman WD. De/remineralization from sodium fluoride dentifrices. Am J Dent. 1995 Aug; 8(4):217-20. PMID: 7576392.
      View in: PubMed
    124. Levy SM, Kohout FJ, Guha-Chowdhury N, Kiritsy MC, Heilman JR, Wefel JS. Infants' fluoride intake from drinking water alone, and from water added to formula, beverages, and food. J Dent Res. 1995 Jul; 74(7):1399-407. PMID: 7560391.
      View in: PubMed
    125. Van Winkle S, Levy SM, Kiritsy MC, Heilman JR, Wefel JS, Marshall T. Water and formula fluoride concentrations: significance for infants fed formula. Pediatr Dent. 1995 Jul-Aug; 17(4):305-10. PMID: 7567636.
      View in: PubMed
    126. Wefel JS, Heilman JR, Jordan TH. Comparisons of in vitro root caries models. Caries Res. 1995; 29(3):204-9. PMID: 7621496.
      View in: PubMed
    127. Wefel JS. Root caries histopathology and chemistry. Am J Dent. 1994 Oct; 7(5):261-5. PMID: 7986449.
      View in: PubMed
    128. Swift EJ, Hammel SA, Perdigao J, Wefel JS. Prevention of root surface caries using a dental adhesive. J Am Dent Assoc. 1994 May; 125(5):571-6. PMID: 8195498.
      View in: PubMed
    129. Ettinger RL, Bergman W, Wefel J. Effect of fluoride on overdenture abutments. Am J Dent. 1994 Feb; 7(1):17-21. PMID: 9115673.
      View in: PubMed
    130. Perdigao J, Swift EJ, Denehy GE, Wefel JS, Donly KJ. In vitro bond strengths and SEM evaluation of dentin bonding systems to different dentin substrates. J Dent Res. 1994 Jan; 73(1):44-55. PMID: 8294617.
      View in: PubMed
    131. Drake DR, Wefel JS, Dunkerson D, Hogle K. The antimicrobial activity of Prevention mouthrinse. Am J Dent. 1993 Oct; 6(5):239-42. PMID: 7880467.
      View in: PubMed
    132. Stookey GK, DePaola PF, Featherstone JD, Fejerskov O, Möller IJ, Rotberg S, Stephen KW, Wefel JS. A critical review of the relative anticaries efficacy of sodium fluoride and sodium monofluorophosphate dentifrices. Caries Res. 1993; 27(4):337-60. PMID: 8402812.
      View in: PubMed
    133. Ettinger RL, Ahmad R, Wefel JS. Effect of fluoride concentrations on overdenture abutments. Am J Dent. 1992 Aug; 5(4):199-202. PMID: 1290609.
      View in: PubMed
    134. Wefel JS. Consensus conference on intra-oral models: patient selection, appliance design, and substrate. J Dent Res. 1992 Apr; 71 Spec No:954. PMID: 1592994.
      View in: PubMed
    135. Wefel JS, Jensen ME. An intra-oral single-section demineralization/remineralization model. J Dent Res. 1992 Apr; 71 Spec No:860-3. PMID: 1592975.
      View in: PubMed
    136. Triolo PT, Wefel JS, Jensen ME. Fluoride-releasing core build-up materials and artificial caries. Am J Dent. 1991 Oct; 4(5):207-10. PMID: 1810328.
      View in: PubMed
    137. Skartveit L, Wefel JS, Ekstrand J. Effect of fluoride amalgams on artificial recurrent enamel and root caries. Scand J Dent Res. 1991 Aug; 99(4):287-94. PMID: 1771374.
      View in: PubMed
    138. Swift EJ, Linden JJ, Wefel JS. Effects of the XR-bonding system on in vitro caries. Am J Dent. 1991 Aug; 4(4):157-61. PMID: 1930838.
      View in: PubMed
    139. Jensen ME, Wefel JS, Hammesfahr PD. Fluoride-releasing liners: in vitro recurrent caries. Gen Dent. 1991 Jan-Feb; 39(1):12-7. PMID: 1855629.
      View in: PubMed
    140. Jensen ME, Garcia-Godoy F, Wefel JS. Artificial root caries in amalgam restorations: effect of light-cured fluoride releasing liners. Am J Dent. 1990 Dec; 3(6):295-8. PMID: 2095808.
      View in: PubMed
    141. Jensen ME, Wefel JS. Effects of processed cheese on human plaque pH and demineralization and remineralization. Am J Dent. 1990 Oct; 3(5):217-23. PMID: 2076251.
      View in: PubMed
    142. Almqvist H, Wefel JS, Lagerlöf F. Root hard-tissue demineralization rate measured by 125I absorptiometry: comparison with lesion-depth measurements. J Dent Res. 1990 Aug; 69(8):1519-21. PMID: 2384629.
      View in: PubMed
    143. Jensen ME, Wefel JS, Triolo PT, Hammesfahr PD. Effects of a fluoride-releasing fissure sealant on artificial enamel caries. Am J Dent. 1990 Apr; 3(2):75-8. PMID: 2076228.
      View in: PubMed
    144. Wefel JS. Effects of fluoride on caries development and progression using intra-oral models. J Dent Res. 1990 Feb; 69 Spec No:626-33; discussion 634-6. PMID: 2179323.
      View in: PubMed
    145. Jensen ME, Wefel JS. Human plaque pH responses to meals and the effects of chewing gum. Br Dent J. 1989 Sep 23; 167(6):204-8. PMID: 2789898.
      View in: PubMed
    146. Hayes PA, Wefel JS. In vivo remineralization of enamel at the buccal and proximal sites using two fluoride regimens. Pediatr Dent. 1988 Dec; 10(4):295-300. PMID: 3272954.
      View in: PubMed
    147. Ettinger RL, Manderson D, Wefel JS, Jensen ME. An in vitro evaluation of the prevention of caries on overdenture abutments. J Dent Res. 1988 Oct; 67(10):1338-41. PMID: 3049716.
      View in: PubMed
    148. Almqvist H, Wefel JS, Lagerlöf F, Ekstrand J, Henrikson CO. In vitro root caries progression measured by 125I absorptiometry: comparison with chemical analysis. J Dent Res. 1988 Sep; 67(9):1217-20. PMID: 3166004.
      View in: PubMed
    149. Sheth JJ, Jesen ME, Wefel JS, Levy SM. Restoration of root caries with dentinal bonding agent and microfilled composite resin: 1-year clinical evaluation. Gerodontics. 1988 Apr; 4(2):71-7. PMID: 3061862.
      View in: PubMed
    150. Kambhu PP, Ettinger RL, Wefel JS. An in vitro evaluation of artificial caries-like lesions on restored overdenture abutments. J Dent Res. 1988 Mar; 67(3):582-4. PMID: 3049717.
      View in: PubMed
    151. Clarkson BH, Hansen SE, Wefel JS. Effect of topical fluoride treatments on fluoride distribution during in vitro caries-like lesion formation. Caries Res. 1988; 22(5):263-8. PMID: 2846177.
      View in: PubMed
    152. Wefel JS, Harless JD. The use of saturated DCPD in remineralization of artificial caries lesions in vitro. J Dent Res. 1987 Nov; 66(11):1640-3. PMID: 10872398.
      View in: PubMed
    153. Wefel JS, Maharry GJ, Jensen ME, Harless JD. Development of an intra-oral single-section remineralization model. J Dent Res. 1987 Sep; 66(9):1485-9. PMID: 3476620.
      View in: PubMed
    154. Clarkson BH, Krell D, Wefel JS, Crall J, Feagin FF. In vitro caries-like lesion production by Streptococcus mutans and Actinomyces viscosus using sucrose and starch. J Dent Res. 1987 Mar; 66(3):795-8. PMID: 3497184.
      View in: PubMed
    155. Nelson DG, Wefel JS, Jongebloed WL, Featherstone JD. Morphology, histology and crystallography of human dental enamel treated with pulsed low-energy infrared laser radiation. Caries Res. 1987; 21(5):411-26. PMID: 3477323.
      View in: PubMed
    156. Clarkson BH, Hall DL, Heilman JR, Wefel JS. Effect of proteolytic enzymes on caries lesion formation in vitro. J Oral Pathol. 1986 Sep; 15(8):423-9. PMID: 3027286.
      View in: PubMed
    157. Clarkson BH, Wefel JS, Feagin FF. Fluoride distribution in enamel after in vitro caries-like lesion formation. J Dent Res. 1986 Jul; 65(7):963-6. PMID: 3458757.
      View in: PubMed
    158. Wefel JS, Clarkson BH, Heilman JR. Natural root caries: a histologic and microradiographic evaluation. J Oral Pathol. 1985 Sep; 14(8):615-23. PMID: 3930671.
      View in: PubMed
    159. Phankosol P, Ettinger RL, Hicks MJ, Wefel JS. Depth of penetration of in vitro root surface lesions. J Dent Res. 1985 Jun; 64(6):897-9. PMID: 3858314.
      View in: PubMed
    160. Phankosol P, Ettinger RL, Hicks MJ, Wefel JS. Histopathology of the initial lesion of the root surface: an in vitro study. J Dent Res. 1985 May; 64(5):804-9. PMID: 3858300.
      View in: PubMed
    161. Feagin FF, Clarkson BH, Wefel JS. Chemical and physical evaluation of dialyzed-reconstituted acidified gelatin surface lesions of human enamel. Caries Res. 1985; 19(3):219-27. PMID: 3857984.
      View in: PubMed
    162. Krell KF, Wefel JS. A calcium phosphate cement root canal sealer--scanning electron microscopic analysis. J Endod. 1984 Dec; 10(12):571-6. PMID: 6394690.
      View in: PubMed
    163. Wefel JS, Harless JD. Comparison of artificial white spots by microradiography and polarized light microscopy. J Dent Res. 1984 Nov; 63(11):1271-5. PMID: 6094633.
      View in: PubMed
    164. Wefel JS, Harless JD. Topical fluoride application and lesion progression in vitro. J Dent Res. 1984 Nov; 63(11):1276-8. PMID: 6594368.
      View in: PubMed
    165. Clarkson BH, Wefel JS, Miller I. A model for producing caries-like lesions in enamel and dentin using oral bacteria in vitro. J Dent Res. 1984 Oct; 63(10):1186-9. PMID: 6592198.
      View in: PubMed
    166. Clarkson BH, Wefel JS, Miller I, Edie J. Microprobe and SEM analysis of surface coatings on caries-like lesions in enamel after metal ion mordanting and APF application. J Dent Res. 1984 Feb; 63(2):106-10. PMID: 6582089.
      View in: PubMed
    167. Clarkson BH, Wefel JS, Miller I. The effect of polyvalent metal ion mordanting on caries-like lesion progression in enamel. J Dent Res. 1984 Jan; 63(1):13-8. PMID: 6582074.
      View in: PubMed
    168. Crall JJ, Wefel JS, Clarkson BH, Silverstone LM, Wei SH. SEM and electron microprobe analysis of enamel treated with two-step topical fluorides in vitro. Caries Res. 1983; 17(6):481-9. PMID: 6580072.
      View in: PubMed
    169. Wefel JS, Harless JD. The effect of several topical fluoride agents on artificial lesion formation. J Dent Res. 1982 Oct; 61(10):1169-71. PMID: 6956599.
      View in: PubMed
    170. Wefel JS. Artificial lesion formation and fluoride uptake after TiF4 applications. Caries Res. 1982; 16(1):26-33. PMID: 6948616.
      View in: PubMed
    171. Crall JJ, Silverstone LM, Clarkson BH, Wefel JS, Wei SH. Fluoride uptake and in vitro caries-like lesion formation in enamel after two-step topical fluoride applications. Caries Res. 1982; 16(2):162-9. PMID: 6951639.
      View in: PubMed
    172. Wefel JS, Harless JD. The effect of topical fluoride agents on fluoride uptake and surface morphology. J Dent Res. 1981 Nov; 60(11):1842-8. PMID: 6945323.
      View in: PubMed
    173. Clarkson BH, Wefel J, Edie J, Wilson M. SEM and microprobe analyses of enamel-metal-fluoride interactions. J Dent Res. 1981 Nov; 60(11):1912-20. PMID: 6945332.
      View in: PubMed
    174. Wei SH, Ngan PW, Wefel JS, Kerber P. Evaluation of fluoride prophylaxis pastes. J Dent Res. 1981 Jul; 60(7):1297-300. PMID: 6940871.
      View in: PubMed
    175. Silverstone LM, Wefel JS, Zimmerman BF, Clarkson BH, Featherstone MJ. Remineralization of natural and artificial lesions in human dental enamel in vitro. Effect of calcium concentration of the calcifying fluid. Caries Res. 1981; 15(2):138-57. PMID: 6937261.
      View in: PubMed
    176. Clarkson BH, Wefel JS, Silverstone LM. Redistribution of enamel fluoride during white spot lesion formation: an in vitro study on human dental enamel. Caries Res. 1981; 15(2):158-65. PMID: 6937262.
      View in: PubMed
    177. Wefel JS, Wei SH. In vitro evaluation of fluoride uptake from a thixotropic gel. Pediatr Dent. 1979 Jun; 1(2):97-100. PMID: 298756.
      View in: PubMed
    178. Clarkson B, Wefel J. Titanium and fluoride concentrations in titanium tetrafluoride and APF treated enamel. J Dent Res. 1979 Feb; 58(2):600-3. PMID: 283090.
      View in: PubMed
    179. Wefel JS, Wei SH. Fluoride supplements for infants and preschool children in nonfluoridated communities. IDAA Commun. 1977 Oct; 12(1):6-7, 20. PMID: 276517.
      View in: PubMed
    180. Wei SH, Wefel JS. Topical fluorides in dental practice. J Prev Dent. 1977 Jul-Aug; 4(4):25-32. PMID: 275482.
      View in: PubMed
    181. Wei SH, Wefel JS, Parkins FM. Fluoride supplements for infants and preschool children. J Prev Dent. 1977 May-Jun; 4(3):28-32. PMID: 269265.
      View in: PubMed
    182. Nancollas GH, Wefel JS. Seeded growth of calcium phosphates: effect of different calcium phosphate seed material. J Dent Res. 1976 Jul-Aug; 55(4):617-24. PMID: 1064608.
      View in: PubMed
    183. Wei SH, Soboroff DM, Wefel JS. Effects of titanium tetrafluoride on human enamel. J Dent Res. 1976 May-Jun; 55(3):426-31. PMID: 1063752.
      View in: PubMed
    184. Wei SH, Wefel JS. In vitro interactions between the surfaces of enamel white spots and calcifying solutions. J Dent Res. 1976 Jan-Feb; 55(1):135-41. PMID: 1060648.
      View in: PubMed
    185. Wei SH, Soboroff MD, Wefel JS, Wolfson S. Relative effects of ammonium fluoride and acidulated phosphate fluoride solutions on human enamel. J Dent Res. 1975 Nov-Dec; 54(6):1234. PMID: 1059665.
      View in: PubMed
    186. Wei SH, Wefel JS. An improved abrasive enamel microsampling device. J Dent Res. 1975 Mar-Apr; 54(2):201-5. PMID: 1054329.
      View in: PubMed
    187. Wei SH, Tang TE, Wefel JS. Reactions of dicalcium phosphate dihydrate with fluoride solutions. J Dent Res. 1974 Sep-Oct; 53(5):1145-54. PMID: 4529543.
      View in: PubMed
    188. Neurocognitive effects.
    189. Cognitive complaints after breast cancer treatments. Breast Diseases. 25:92-93.
    190. Whole-brain irradiation for patients with brain metastases. The Lancet Oncology. 11:223.
    191. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psycho-Oncology.
    192. Chemotherapy-related changes in cognitive functioning. European Journal of Cancer, Supplement. 11:225-232.
    193. Monitoring and optimising cognitive function in cancer patients. European Journal of Cancer, Supplement. 12:29-40.
    194. Verbal Learning Processes in Patients with Glioma of the Left and Right Temporal Lobes. Archives of Clinical Neuropsychology. 31:37-46.
    195. Catechol-o-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Breast Diseases. 22:411-412.
    196. Impact of Cancer and Its Treatments on Cognitive Function. Journal of Pain and Symptom Management. 50:830-841.
    197. Neurocognitive functioning in patients with glioma of the left and right temporal lobes. Journal of Neuro-Oncology. 1-9.
    198. Erratum. International Journal of Radiation Oncology Biology Physics. 84.
    199. Neuropsychological assessment of adults with cancer. 44-55.
    200. Reply to acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 117:1103.
    201. Cognitive dysfunction related to chemotherapy and biological response modifiers. 97-114.
    202. Clinical outcome assessment in malignant glioma trials. Neuro-Oncology. 18:ii13-ii20.
    203. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma. Journal of Neuro-Oncology. 1-10.
    204. Neurocognitive changes associated with surgical resection of left and right temporal lobe glioma. Neurosurgery. 77:777-785.
    205. A randomized trial of bevacizumab for newly diagnosed glioblastoma. New England Journal of Medicine. 370:699-708.
    206. Erratum. Current Neurology and Neuroscience Reports. 12:340.
    207. Genetic modulation of neurocognitive function in glioma patients. Clinical Cancer Research. 21:3340-3346.
    208. Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Scientific Reports. 6.
    209. Neurocognitive testing in clinical trials. 320-328.
    WEFEL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description